These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 19890254)

  • 1. A pharmacovigilance program from laboratory signals for the detection and reporting of serious adverse drug reactions in hospitalized patients.
    Ramirez E; Carcas AJ; Borobia AM; Lei SH; Piñana E; Fudio S; Frias J
    Clin Pharmacol Ther; 2010 Jan; 87(1):74-86. PubMed ID: 19890254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing an adverse drug reaction reporting system at a teaching hospital.
    Baniasadi S; Fahimi F; Shalviri G
    Basic Clin Pharmacol Toxicol; 2008 Apr; 102(4):408-11. PubMed ID: 18312492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.
    Kane-Gill SL; Van Den Bos J; Handler SM
    Ann Pharmacother; 2010 Jun; 44(6):983-93. PubMed ID: 20442350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underreporting of recognized adverse drug reactions by primary care physicians: an exploratory study.
    González-Rubio F; Calderón-Larrañaga A; Poblador-Plou B; Navarro-Pemán C; López-Cabañas A; Prados-Torres A
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1287-94. PubMed ID: 21702073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions in patients in an Iranian department of internal medicine.
    Pourseyed S; Fattahi F; Pourpak Z; Gholami K; Shariatpanahi SS; Moin A; Kazemnejad A; Moin M
    Pharmacoepidemiol Drug Saf; 2009 Feb; 18(2):104-10. PubMed ID: 19101919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals.
    Takata GS; Mason W; Taketomo C; Logsdon T; Sharek PJ
    Pediatrics; 2008 Apr; 121(4):e927-35. PubMed ID: 18381521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacovigilance: characteristics of the most widely used drugs in Bulgaria.
    Getov I; Dimitrova Z
    Cent Eur J Public Health; 1999 Aug; 7(3):133-6. PubMed ID: 10499144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computerized surveillance of adverse drug reactions in hospital: implementation.
    Levy M; Azaz-Livshits T; Sadan B; Shalit M; Geisslinger G; Brune K
    Eur J Clin Pharmacol; 1999 Jan; 54(11):887-92. PubMed ID: 10027665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization.
    von Euler M; Eliasson E; Ohlén G; Bergman U
    Pharmacoepidemiol Drug Saf; 2006 Mar; 15(3):179-84. PubMed ID: 16184621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An internal standard for verifying the accuracy of serious adverse event reporting: the example of an acupuncture study of 190,924 patients.
    Endres HG; Molsberger A; Lungenhausen M; Trampisch HJ
    Eur J Med Res; 2004 Dec; 9(12):545-51. PubMed ID: 15689300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confusion, a rather serious adverse drug reaction with valproic acid: a review of the French Pharmacovigilance database.
    Bondon-Guitton E; Sommet A; Montastruc JL;
    Pharmacopsychiatry; 2009 Mar; 42(2):61-5. PubMed ID: 19308880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients.
    Holdsworth MT; Fichtl RE; Raisch DW; Hewryk A; Behta M; Mendez-Rico E; Wong CL; Cohen J; Bostwick S; Greenwald BM
    Pediatrics; 2007 Nov; 120(5):1058-66. PubMed ID: 17974744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward].
    Tribiño G; Maldonado C; Segura O; Díaz J
    Biomedica; 2006 Mar; 26(1):31-41. PubMed ID: 16929901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacovigilance through consumer feedback (reporting) in the mass treatment of lymphatic filariasis using diethylcarbamazine and albendazole in two districts of Sri Lanka.
    Gunawardena S; Sri Ranganathan S; Fernandopulle R
    Trop Med Int Health; 2008 Sep; 13(9):1153-8. PubMed ID: 18631319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.